Putnam Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Putnam Investments’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,141	Closed	-$942K	–	1305
2021 Q4	$942K	Buy	+10,141	New	+$668K	﹤0.01%	869

Putnam Investments's ARNA Position: Q1 2022 in Review

Putnam Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 10,141 shares — an estimated $942K sold.

Putnam Investments first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $942K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Putnam Investments reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Putnam Investments sold 10,141 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $942K.
Putnam Investments first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Putnam Investments's Arena Pharmaceuticals Inc position peaked at $942K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Putnam Investments's 13F filing for Q1 2022, filed 16 May 2022.